{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:59:27Z","timestamp":1783360767656,"version":"3.54.6"},"publisher-location":"New York, NY","reference-count":220,"publisher":"Springer US","isbn-type":[{"value":"9781071641873","type":"print"},{"value":"9781071641880","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4188-0_1","type":"book-chapter","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:03:07Z","timestamp":1729274587000},"page":"1-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Marc A.","family":"Weniger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/302575a0","volume":"302","author":"S Tonegawa","year":"1983","unstructured":"Tonegawa S (1983) Somatic generation of antibody diversity. Nature 302:575\u2013581","journal-title":"Nature"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0092-8674(00)81086-7","volume":"85","author":"DC van Gent","year":"1996","unstructured":"van Gent DC, Ramsden DA, Gellert M (1996) The RAG1 and RAG2 proteins establish the 12\/23 rule in V(D)J recombination. Cell 85:107\u2013113","journal-title":"Cell"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.moh.0000160735.67596.a0","volume":"12","author":"KL Medina","year":"2005","unstructured":"Medina KL, Singh H (2005) Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol 12:203\u2013209","journal-title":"Curr Opin Hematol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381:751\u2013758","journal-title":"Nature"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1006\/jmbi.1997.1141","volume":"270","author":"SJ Corbett","year":"1997","unstructured":"Corbett SJ, Tomlinson IM, Sonnhammer EL et al (1997) Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, \u201cminor\u201d D segments or D-D recombination. J Mol Biol 270:587\u2013597","journal-title":"J Mol Biol"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0092-8674(81)90400-1","volume":"27","author":"JV Ravetch","year":"1981","unstructured":"Ravetch JV, Siebenlist U, Korsmeyer S et al (1981) Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell 27:583\u2013591","journal-title":"Cell"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0167-5699(95)80166-9","volume":"16","author":"GP Cook","year":"1995","unstructured":"Cook GP, Tomlinson IM (1995) The human immunoglobulin VH repertoire. Immunol Today 16:237\u2013242","journal-title":"Immunol Today"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1749-6632.1992.tb24626.x","volume":"651","author":"FW Alt","year":"1992","unstructured":"Alt FW, Rathbun G, Oltz E et al (1992) Function and control of recombination-activating gene activity. Ann N Y Acad Sci 651:277\u2013294","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.it.2007.01.003","volume":"28","author":"Z Zhang","year":"2007","unstructured":"Zhang Z (2007) VH replacement in mice and humans. Trends Immunol 28:132\u2013137","journal-title":"Trends Immunol"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1084\/jem.177.4.1009","volume":"177","author":"SL Tiegs","year":"1993","unstructured":"Tiegs SL, Russell DM, Nemazee D (1993) Receptor editing in self-reactive bone marrow B cells. J Exp Med 177:1009\u20131020","journal-title":"J Exp Med"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/S0021-9258(19)68223-2","volume":"257","author":"PA Hieter","year":"1982","unstructured":"Hieter PA, Maizel JV Jr, Leder P (1982) Evolution of human immunoglobulin kappa J region genes. J Biol Chem 257:1516\u20131522","journal-title":"J Biol Chem"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1515\/bchm3.1993.374.7-12.1001","volume":"374","author":"KF Sch\u00e4ble","year":"1993","unstructured":"Sch\u00e4ble KF, Zachau HG (1993) The variable genes of the human immunoglobulin kappa locus. Biol Chem Hoppe Seyler 374:1001\u20131022","journal-title":"Biol Chem Hoppe Seyler"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1101\/gr.7.3.250","volume":"7","author":"K Kawasaki","year":"1997","unstructured":"Kawasaki K, Minoshima S, Nakato E et al (1997) One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 7:250\u2013261","journal-title":"Genome Res"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1084\/jem.172.2.609","volume":"172","author":"TJ Vasicek","year":"1990","unstructured":"Vasicek TJ, Leder P (1990) Structure and expression of the human immunoglobulin lambda genes. J Exp Med 172:609\u2013620","journal-title":"J Exp Med"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/1521-4141(200112)31:12<3631::AID-IMMU3631>3.0.CO;2-L","volume":"31","author":"A Br\u00e4uninger","year":"2001","unstructured":"Br\u00e4uninger A, Goossens T, Rajewsky K et al (2001) Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol 31:3631\u20133637","journal-title":"Eur J Immunol"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0161-5890(98)00029-7","volume":"35","author":"B Nadel","year":"1998","unstructured":"Nadel B, Tang A, Feeney AJ (1998) V(H) replacement is unlikely to contribute significantly to receptor editing due to an ineffectual embedded recombination signal sequence. Mol Immunol 35:227\u2013232","journal-title":"Mol Immunol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-7613(03)00170-5","volume":"19","author":"Z Zhang","year":"2003","unstructured":"Zhang Z, Zemlin M, Wang YH et al (2003) Contribution of Vh gene replacement to the primary B cell repertoire. Immunity 19:21\u201331","journal-title":"Immunity"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"GD Victora","year":"2022","unstructured":"Victora GD, Nussenzweig MC (2022) Germinal centers. Annu Rev Immunol 40:413\u2013442","journal-title":"Annu Rev Immunol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/ni.2418","volume":"13","author":"DP Calado","year":"2012","unstructured":"Calado DP, Sasaki Y, Godinho SA et al (2012) The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat Immunol 13:1092\u20131100","journal-title":"Nat Immunol"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/ni.2428","volume":"13","author":"D Dominguez-Sola","year":"2012","unstructured":"Dominguez-Sola D, Victora GD, Ying CY et al (2012) The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13:1083\u20131091","journal-title":"Nat Immunol"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1002\/j.1460-2075.1993.tb06189.x","volume":"12","author":"R K\u00fcppers","year":"1993","unstructured":"K\u00fcppers R, Zhao M, Hansmann ML et al (1993) Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 12:4955\u20134967","journal-title":"EMBO J"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1073\/pnas.95.5.2463","volume":"95","author":"T Goossens","year":"1998","unstructured":"Goossens T, Klein U, K\u00fcppers R (1998) Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 95:2463\u20132468","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-387663-8.00005-3","volume":"110","author":"R Pavri","year":"2011","unstructured":"Pavri R, Nussenzweig MC (2011) AID targeting in antibody diversity. Adv Immunol 110:1\u201326","journal-title":"Adv Immunol"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.icb.7100160","volume":"86","author":"MS Neuberger","year":"2008","unstructured":"Neuberger MS (2008) Antibody diversification by somatic mutation: from Burnet onwards. Immunol Cell Biol 86:124\u2013132","journal-title":"Immunol Cell Biol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","volume":"76","author":"JM Di Noia","year":"2007","unstructured":"Di Noia JM, Neuberger MST (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76:1\u201322","journal-title":"Annu Rev Biochem"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1073\/pnas.95.20.11816","volume":"95","author":"L Pasqualucci","year":"1998","unstructured":"Pasqualucci L, Migliazza A, Fracchiolla N et al (1998) BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95:11816\u201311821","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature06547","volume":"451","author":"M Liu","year":"2008","unstructured":"Liu M, Duke JL, Richter DJ et al (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451:841\u2013845","journal-title":"Nature"},{"issue":"324-336","key":"1_CR28","volume":"51","author":"S Finkin","year":"2019","unstructured":"Finkin S, Hartweger H, Oliveira TY et al (2019) Protein amounts of the MYC transcription factor determine germinal center B cell division capacity. Immunity 51(324-336):e325","journal-title":"Immunity"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1172\/JCI95993","volume":"128","author":"MA Weniger","year":"2018","unstructured":"Weniger MA, Tiacci E, Schneider S et al (2018) Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest 128:2996\u20133007","journal-title":"J Clin Invest"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1471-4906(01)02111-1","volume":"23","author":"JP Manis","year":"2002","unstructured":"Manis JP, Tian M, Alt FW (2002) Mechanism and control of class-switch recombination. Trends Immunol 23:31\u201339","journal-title":"Trends Immunol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","volume":"188","author":"U Klein","year":"1998","unstructured":"Klein U, Rajewsky K, K\u00fcppers R (1998) Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188:1679\u20131689","journal-title":"J Exp Med"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1084\/jem.20091087","volume":"206","author":"M Seifert","year":"2009","unstructured":"Seifert M, K\u00fcppers R (2009) Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 206:2659\u20132669","journal-title":"J Exp Med"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"E5281","DOI":"10.1073\/pnas.1511270112","volume":"112","author":"B Budeus","year":"2015","unstructured":"Budeus B, Schweigle de Reynoso S, Przekopowitz M et al (2015) Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers. Proc Natl Acad Sci USA 112:E5281\u2013E5289","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"eabe6291","DOI":"10.1126\/sciimmunol.abe6291","volume":"6","author":"HW King","year":"2021","unstructured":"King HW, Orban N, Riches JC et al (2021) Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics. Sci Immunol 6:eabe6291","journal-title":"Sci Immunol"},{"issue":"337-350","key":"1_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.07.001","volume":"51","author":"JA Roco","year":"2019","unstructured":"Roco JA, Mesin L, Binder SC et al (2019) Class-switch recombination occurs infrequently in germinal centers. Immunity 51(337-350):e337","journal-title":"Immunity"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-immunol-093019-125603","volume":"39","author":"TJ Ripperger","year":"2021","unstructured":"Ripperger TJ, Bhattacharya D (2021) Transcriptional and metabolic control of memory B cells and plasma cells. Annu Rev Immunol 39:345\u2013368","journal-title":"Annu Rev Immunol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/leu.2016.226","volume":"30","author":"M Seifert","year":"2016","unstructured":"Seifert M, K\u00fcppers R (2016) Human memory B cells. Leukemia 30:2283\u20132292","journal-title":"Leukemia"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3128","volume":"12","author":"M McHeyzer-Williams","year":"2012","unstructured":"McHeyzer-Williams M, Okitsu S, Wang N et al (2012) Molecular programming of B cell memory. Nat Rev Immunol 12:24\u201334","journal-title":"Nat Rev Immunol"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.23.021704.115723","volume":"23","author":"RA Manz","year":"2005","unstructured":"Manz RA, Hauser AE, Hiepe F et al (2005) Maintenance of serum antibody levels. Annu Rev Immunol 23:367\u2013386","journal-title":"Annu Rev Immunol"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1308378","DOI":"10.3389\/fimmu.2023.1308378","volume":"14","author":"B Budeus","year":"2023","unstructured":"Budeus B, Kibler A, K\u00fcppers R (2023) Human IgM-expressing memory B cells. Front Immunol 14:1308378","journal-title":"Front Immunol"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.immuni.2007.05.018","volume":"27","author":"JH Han","year":"2007","unstructured":"Han JH, Akira S, Calame K et al (2007) Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity 27:64\u201375","journal-title":"Immunity"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1146\/annurev.iy.13.040195.003255","volume":"13","author":"JJ Mond","year":"1995","unstructured":"Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol 13:655\u2013692","journal-title":"Annu Rev Immunol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20011112","volume":"195","author":"KM Toellner","year":"2002","unstructured":"Toellner KM, Jenkinson WE, Taylor DR et al (2002) Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med 195:383\u2013389","journal-title":"J Exp Med"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8:22\u201333","journal-title":"Nat Rev Immunol"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5:251\u2013262","journal-title":"Nat Rev Cancer"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","volume":"131","author":"R K\u00fcppers","year":"2018","unstructured":"K\u00fcppers R, Stevenson FK (2018) Critical influences on the pathogenesis of follicular lymphoma. Blood 131:2297\u20132306","journal-title":"Blood"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/sj.leu.2404426","volume":"21","author":"RJ Bende","year":"2007","unstructured":"Bende RJ, Smit LA, van Noesel CJ (2007) Molecular pathways in follicular lymphoma. Leukemia 21:18\u201329","journal-title":"Leukemia"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"R K\u00fcppers","year":"1999","unstructured":"K\u00fcppers R, Klein U, Hansmann M-L et al (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520\u20131529","journal-title":"N Engl J Med"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511","journal-title":"Nature"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937\u20131947","journal-title":"N Engl J Med"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"10209","DOI":"10.1073\/pnas.180316097","volume":"97","author":"IS Lossos","year":"2000","unstructured":"Lossos IS, Alizadeh AA, Eisen MB et al (2000) Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA 97:10209\u201310213","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35:968\u2013981","journal-title":"Leukemia"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","volume":"184","author":"H Kanzler","year":"1996","unstructured":"Kanzler H, K\u00fcppers R, Hansmann ML et al (1996) Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184:1495\u20131505","journal-title":"J Exp Med"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","volume":"91","author":"R K\u00fcppers","year":"1994","unstructured":"K\u00fcppers R, Rajewsky K, Zhao M et al (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962\u201310966","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","volume":"15","author":"K Basso","year":"2015","unstructured":"Basso K, Dalla-Favera R (2015) Germinal centres and B cell lymphomagenesis. Nat Rev Immunol 15:172\u2013184","journal-title":"Nat Rev Immunol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nature03147","volume":"432","author":"RT Phan","year":"2004","unstructured":"Phan RT, Dalla-Favera R (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432:635\u2013639","journal-title":"Nature"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"238ra271","DOI":"10.1126\/scitranslmed.3008004","volume":"6","author":"SS Chung","year":"2014","unstructured":"Chung SS, Kim E, Park JH et al (2014) Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia. Sci Transl Med 6:238ra271","journal-title":"Sci Transl Med"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","volume":"4","author":"F Damm","year":"2014","unstructured":"Damm F, Mylonas E, Cosson A et al (2014) Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov 4:1088\u20131101","journal-title":"Cancer Discov"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NC, Lamy L et al (2008) IRF4 addiction in multiple myeloma. Nature 454:226\u2013231","journal-title":"Nature"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20031175","volume":"199","author":"K Basso","year":"2004","unstructured":"Basso K, Liso A, Tiacci E et al (2004) Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med 199:59\u201368","journal-title":"J Exp Med"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1084\/jem.20120833","volume":"209","author":"M Seifert","year":"2012","unstructured":"Seifert M, Sellmann L, Bloehdorn J et al (2012) Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 209:2183\u20132198","journal-title":"J Exp Med"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","volume":"194","author":"U Klein","year":"2001","unstructured":"Klein U, Tu Y, Stolovitzky GA et al (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194:1625\u20131638","journal-title":"J Exp Med"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","volume":"20","author":"R K\u00fcppers","year":"2001","unstructured":"K\u00fcppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580\u20135594","journal-title":"Oncogene"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35085588","volume":"412","author":"L Pasqualucci","year":"2001","unstructured":"Pasqualucci L, Neumeister P, Goossens T et al (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341\u2013346","journal-title":"Nature"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood.V95.11.3520","volume":"95","author":"U J\u00e4ger","year":"2000","unstructured":"J\u00e4ger U, Bocskor S, Le T et al (2000) Follicular lymphomas\u2019 BCL-2\/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95:3520\u20133529","journal-title":"Blood"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.3929382","volume":"229","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto Y, Gorham J, Cossman J et al (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390\u20131393","journal-title":"Science"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1126\/science.6401867","volume":"219","author":"R Dalla-Favera","year":"1983","unstructured":"Dalla-Favera R, Martinotti S, Gallo RC et al (1983) Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219:963\u2013967","journal-title":"Science"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","volume":"79","author":"R Taub","year":"1982","unstructured":"Taub R, Kirsch I, Morton C et al (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837\u20137841","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1182\/blood.V88.4.1177.bloodjournal8841177","volume":"88","author":"JW Vaandrager","year":"1996","unstructured":"Vaandrager JW, Schuuring E, Zwikstra E et al (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88:1177\u20131182","journal-title":"Blood"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1073\/pnas.90.11.5262","volume":"90","author":"BW Baron","year":"1993","unstructured":"Baron BW, Nucifora G, McCabe N et al (1993) Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262\u20135266","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","volume":"101","author":"I Wlodarska","year":"2003","unstructured":"Wlodarska I, Nooyen P, Maes B et al (2003) Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 101:706\u2013710","journal-title":"Blood"},{"key":"1_CR72","first-page":"2732","volume":"53","author":"BH Ye","year":"1993","unstructured":"Ye BH, Rao PH, Chaganti RS et al (1993) Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 53:2732\u20132735","journal-title":"Cancer Res"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm J, Baens M, Wlodarska I et al (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601\u20133609","journal-title":"Blood"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298\u2013303","journal-title":"Nature"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189\u2013195","journal-title":"Nature"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/leu.2011.194","volume":"26","author":"O Ammerpohl","year":"2011","unstructured":"Ammerpohl O, Haake A, Pellissery S et al (2011) Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes. Leukemia 26:185\u2013188","journal-title":"Leukemia"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1182\/blood-2008-04-152900","volume":"113","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Kreuz M, Bibikova M et al (2009) New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113:2488\u20132497","journal-title":"Blood"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41586-022-04906-8","volume":"607","author":"E Bal","year":"2022","unstructured":"Bal E, Kumar R, Hadigol M et al (2022) Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature 607:808\u2013815","journal-title":"Nature"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D et al (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307\u2013319","journal-title":"Cell"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","volume":"24","author":"B Chapuy","year":"2013","unstructured":"Chapuy B, McKeown MR, Lin CY et al (2013) Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24:777\u2013790","journal-title":"Cancer Cell"},{"key":"1_CR81","first-page":"589","volume":"84","author":"A Cuneo","year":"1999","unstructured":"Cuneo A, Bigoni R, Rigolin GM et al (1999) 13q14 deletion in non-Hodgkin\u2019s lymphoma: correlation with clinicopathologic features. Haematologica 84:589\u2013593","journal-title":"Haematologica"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrc746","volume":"2","author":"WM Kuehl","year":"2002","unstructured":"Kuehl WM, Bergsagel PL (2002) Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2:175\u2013187","journal-title":"Nat Rev Cancer"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1182\/blood.V86.5.1911.bloodjournal8651911","volume":"86","author":"Y Liu","year":"1995","unstructured":"Liu Y, Hermanson M, Grander D et al (1995) 13q deletions in lymphoid malignancies. Blood 86:1911\u20131915","journal-title":"Blood"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","volume":"17","author":"U Klein","year":"2010","unstructured":"Klein U, Lia M, Crespo M et al (2010) The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28\u201340","journal-title":"Cancer Cell"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24:679\u2013690","journal-title":"Nat Med"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW et al (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378:1396\u20131407","journal-title":"N Engl J Med"},{"issue":"551-568","key":"1_CR87","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD et al (2020) A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell 37(551-568):e514","journal-title":"Cancer Cell"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.3413","volume":"47","author":"H Kretzmer","year":"2015","unstructured":"Kretzmer H, Bernhart SH, Wang W et al (2015) DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. Nat Genet 47:1316\u20131325","journal-title":"Nat Genet"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis M, Heath S, Bibikova M et al (2012) Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 44:1236\u20131242","journal-title":"Nat Genet"},{"key":"1_CR90","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes CC, Seifert M, Assenov Y et al (2016) DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet 48:253\u2013264","journal-title":"Nat Genet"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/leu.2014.252","volume":"29","author":"AC Queiros","year":"2015","unstructured":"Queiros AC, Villamor N, Clot G et al (2015) A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 29:598\u2013605","journal-title":"Leukemia"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","volume":"26","author":"DA Landau","year":"2014","unstructured":"Landau DA, Clement K, Ziller MJ et al (2014) Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell 26:813\u2013825","journal-title":"Cancer Cell"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","volume":"30","author":"AC Queiros","year":"2016","unstructured":"Queiros AC, Beekman R, Vilarrasa-Blasi R et al (2016) Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage. Cancer Cell 30:806\u2013821","journal-title":"Cancer Cell"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2141.2007.06879.x","volume":"140","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A (2008) KSHV\/HHV8-associated lymphomas. Br J Haematol 140:13\u201324","journal-title":"Br J Haematol"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nri1201","volume":"3","author":"R K\u00fcppers","year":"2003","unstructured":"K\u00fcppers R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801\u2013812","journal-title":"Nat Rev Immunol"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","volume":"17","author":"E Kilger","year":"1998","unstructured":"Kilger E, Kieser A, Baumann M et al (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17:1700\u20131709","journal-title":"EMBO J"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","volume":"106","author":"D Bechtel","year":"2005","unstructured":"Bechtel D, Kurth J, Unkel C et al (2005) Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood 106:4345\u20134350","journal-title":"Blood"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","volume":"110","author":"C Mancao","year":"2007","unstructured":"Mancao C, Hammerschmidt W (2007) Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110:3715\u20133721","journal-title":"Blood"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/ijc.21716","volume":"118","author":"A Br\u00e4uninger","year":"2006","unstructured":"Br\u00e4uninger A, Schmitz R, Bechtel D et al (2006) Molecular biology of Hodgkin and Reed\/Sternberg cells in Hodgkin\u2019s lymphoma. Int J Cancer 118:1853\u20131861","journal-title":"Int J Cancer"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","volume":"98","author":"ER Quinn","year":"2001","unstructured":"Quinn ER, Chan CH, Hadlock KG et al (2001) The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98:3745\u20133749","journal-title":"Blood"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.1128\/JVI.78.16.8835-8843.2004","volume":"78","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT, Sung VM et al (2004) Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78:8835\u20138843","journal-title":"J Virol"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT, Sung VM et al (2004) Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101:4262\u20134267","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1128\/JVI.03081-12","volume":"87","author":"FA Tucci","year":"2013","unstructured":"Tucci FA, Broering R, Johansson P et al (2013) B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes. J Virol 87:2956\u20132962","journal-title":"J Virol"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1158\/1078-0432.CCR-10-0470","volume":"16","author":"A Lacroix","year":"2010","unstructured":"Lacroix A, Collot-Teixeira S, Mardivirin L et al (2010) Involvement of human herpesvirus-6 variant B in classic Hodgkin\u2019s lymphoma via DR7 oncoprotein. Clin Cancer Res 16:4711\u20134721","journal-title":"Clin Cancer Res"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ijc.22628","volume":"121","author":"E Maggio","year":"2007","unstructured":"Maggio E, Benharroch D, Gopas J et al (2007) Absence of measles virus genome and transcripts in Hodgkin-Reed\/Sternberg cells of a cohort of Hodgkin lymphoma patients. Int J Cancer 121:448\u2013453","journal-title":"Int J Cancer"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V82.6.1848.1848","volume":"82","author":"PW Johnson","year":"1993","unstructured":"Johnson PW, Watt SM, Betts DR et al (1993) Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40\/stromal cell system. Blood 82:1848\u20131857","journal-title":"Blood"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.4049\/jimmunol.144.7.2550","volume":"144","author":"DT Umetsu","year":"1990","unstructured":"Umetsu DT, Esserman L, Donlon TA et al (1990) Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 144:2550\u20132557","journal-title":"J Immunol"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","volume":"99","author":"D Zhu","year":"2002","unstructured":"Zhu D, McCarthy H, Ottensmeier CH et al (2002) Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99:2562\u20132568","journal-title":"Blood"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"18587","DOI":"10.1073\/pnas.1009388107","volume":"107","author":"V Coelho","year":"2010","unstructured":"Coelho V, Krysov S, Ghaemmaghami AM et al (2010) Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci USA 107:18587\u201318592","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2559.1994.tb00553.x","volume":"24","author":"C Schmid","year":"1994","unstructured":"Schmid C, Isaacson PG (1994) Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathology 24:445\u2013451","journal-title":"Histopathology"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","volume":"32","author":"P Ghia","year":"2002","unstructured":"Ghia P, Strola G, Granziero L et al (2002) Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 32:1403\u20131413","journal-title":"Eur J Immunol"},{"key":"1_CR112","first-page":"329","volume":"25","author":"C Buske","year":"1997","unstructured":"Buske C, Gogowski G, Schreiber K et al (1997) Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Exp Hematol 25:329\u2013337","journal-title":"Exp Hematol"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1358.002","volume":"1062","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Hatzi K, Albesiano E (2005) B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N Y Acad Sci 1062:1\u201312","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065203","volume":"8","author":"X Que","year":"2013","unstructured":"Que X, Widhopf GF 2nd, Amir S et al (2013) IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. PLoS One 8:e65203","journal-title":"PLoS One"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","volume":"115","author":"CC Chu","year":"2010","unstructured":"Chu CC, Catera R, Zhang L et al (2010) Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 115:3907\u20133915","journal-title":"Blood"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1172\/JCI24387","volume":"115","author":"M Herve","year":"2005","unstructured":"Herve M, Xu K, Ng YS et al (2005) Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 115:1636\u20131643","journal-title":"J Clin Invest"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M D\u00fchren-von Minden","year":"2012","unstructured":"D\u00fchren-von Minden M, Ubelhart R, Schneider D et al (2012) Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489:309\u2013312","journal-title":"Nature"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"13447","DOI":"10.1073\/pnas.1514944112","volume":"112","author":"RM Young","year":"2015","unstructured":"Young RM, Wu T, Schmitz R et al (2015) Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proc Natl Acad Sci USA 112:13447\u201313454","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/leu.2011.276","volume":"26","author":"A Dagklis","year":"2012","unstructured":"Dagklis A, Ponzoni M, Govi S et al (2012) Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Leukemia 26:814\u2013821","journal-title":"Leukemia"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molimm.2014.03.009","volume":"60","author":"A Mahendra","year":"2014","unstructured":"Mahendra A, Gangadharan B, Andre S et al (2014) Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma. Mol Immunol 60:54\u201361","journal-title":"Mol Immunol"},{"key":"1_CR121","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1084\/jem.20050068","volume":"201","author":"RJ Bende","year":"2005","unstructured":"Bende RJ, Aarts WM, Riedl RG et al (2005) Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 201:1229\u20131241","journal-title":"J Exp Med"},{"key":"1_CR122","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D","volume":"178","author":"T Hussel","year":"1996","unstructured":"Hussel T, Isaacson PG, Crabtree JE et al (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122\u2013127","journal-title":"J Pathol"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"AC Wotherspoon","year":"1993","unstructured":"Wotherspoon AC, Doglioni C, Diss TC et al (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 342:575\u2013577","journal-title":"Lancet"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki JP et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89\u201394","journal-title":"N Engl J Med"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3324\/haematol.2023.282698","volume":"108","author":"L Thurner","year":"2023","unstructured":"Thurner L, Fadle N, Regitz E et al (2023) B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma. Haematologica 108:3347\u20133358","journal-title":"Haematologica"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","volume":"11","author":"L Thurner","year":"2020","unstructured":"Thurner L, Hartmann S, Fadle N et al (2020) Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun 11:2465","journal-title":"Nat Commun"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R K\u00fcppers","year":"2009","unstructured":"K\u00fcppers R (2009) The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer 9:15\u201327","journal-title":"Nat Rev Cancer"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","volume":"103","author":"NA Marshall","year":"2004","unstructured":"Marshall NA, Christie LE, Munro LR et al (2004) Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103:1755\u20131762","journal-title":"Blood"},{"key":"1_CR129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1189\/jlb.3MR0315-136R","volume":"99","author":"F Wein","year":"2016","unstructured":"Wein F, K\u00fcppers R (2016) The role of T cells in the microenvironment of Hodgkin lymphoma. J Leukoc Biol 99:45\u201350","journal-title":"J Leukoc Biol"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","volume":"110","author":"JM Chemnitz","year":"2007","unstructured":"Chemnitz JM, Eggle D, Driesen J et al (2007) RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood 110:3226\u20133233","journal-title":"Blood"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","volume":"110","author":"MK Gandhi","year":"2007","unstructured":"Gandhi MK, Moll G, Smith C et al (2007) Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Blood 110:1326\u20131329","journal-title":"Blood"},{"key":"1_CR132","doi-asserted-by":"publisher","first-page":"13134","DOI":"10.1073\/pnas.0706017104","volume":"104","author":"P Juszczynski","year":"2007","unstructured":"Juszczynski P, Ouyang J, Monti S et al (2007) The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 104:13134\u201313139","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","volume":"111","author":"R Yamamoto","year":"2008","unstructured":"Yamamoto R, Nishikori M, Kitawaki T et al (2008) PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111:3220\u20133224","journal-title":"Blood"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","volume":"5","author":"F Wein","year":"2017","unstructured":"Wein F, Weniger MA, Hoing B et al (2017) Complex immune evasion strategies in classical Hodgkin lymphoma. Cancer Immunol Res 5:1122\u20131132","journal-title":"Cancer Immunol Res"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","volume":"30","author":"AL Shaffer","year":"2012","unstructured":"Shaffer AL, Young RM, Staudt LM (2012) Pathogenesis of human B cell lymphomas. Annu Rev Immunol 30:565\u2013610","journal-title":"Annu Rev Immunol"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V99.1.238","volume":"99","author":"E Camacho","year":"2002","unstructured":"Camacho E, Hernandez L, Hernandez S et al (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99:238\u2013244","journal-title":"Blood"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1073\/pnas.050400997","volume":"97","author":"C Schaffner","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S et al (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97:2773\u20132778","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7:750\u2013762","journal-title":"Nat Rev Cancer"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/leu.2009.234","volume":"24","author":"E Chanudet","year":"2010","unstructured":"Chanudet E, Huang Y, Ichimura K et al (2010) A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 24:483\u2013487","journal-title":"Leukemia"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"38180","DOI":"10.18632\/oncotarget.9500","volume":"7","author":"C Wu","year":"2016","unstructured":"Wu C, de Miranda NF, Chen L et al (2016) Genetic heterogeneity in primary and relapsed mantle cell lymphomas: impact of recurrent CARD11 mutations. Oncotarget 7:38180\u201338190","journal-title":"Oncotarget"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","volume":"119","author":"R Kridel","year":"2012","unstructured":"Kridel R, Meissner B, Rogic S et al (2012) Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119:1963\u20131971","journal-title":"Blood"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea S, Valdes-Mas R, Navarro A et al (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA 110:18250\u201318255","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/blood.V94.2.748","volume":"94","author":"C Schaffner","year":"1999","unstructured":"Schaffner C, Stilgenbauer S, Rappold GA et al (1999) Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94:748\u2013753","journal-title":"Blood"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","volume":"353","author":"T Stankovic","year":"1999","unstructured":"Stankovic T, Weber P, Stewart G et al (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26\u201329","journal-title":"Lancet"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G Gaidano","year":"1991","unstructured":"Gaidano G, Ballerini P, Gong JZ et al (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413\u20135417","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D et al (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 208:1389\u20131401","journal-title":"J Exp Med"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V et al (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101\u2013105","journal-title":"Nature"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2011","unstructured":"Quesada V, Conde L, Villamor N et al (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47\u201352","journal-title":"Nat Genet"},{"key":"1_CR149","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D, Bruscaggin A, Spina V et al (2011) Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 118:6904\u20136908","journal-title":"Blood"},{"key":"1_CR150","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","volume":"121","author":"MR Green","year":"2013","unstructured":"Green MR, Gentles AJ, Nair RV et al (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121:1604\u20131611","journal-title":"Blood"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/leu.2011.266","volume":"26","author":"E Launay","year":"2012","unstructured":"Launay E, Pangault C, Bertrand P et al (2012) High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia 26:559\u2013562","journal-title":"Leukemia"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181\u2013185","journal-title":"Nat Genet"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","volume":"123","author":"H Li","year":"2014","unstructured":"Li H, Kaminski MS, Li Y et al (2014) Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. Blood 123:1487\u20131498","journal-title":"Blood"},{"key":"1_CR154","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ni.2688","volume":"14","author":"CY Ying","year":"2013","unstructured":"Ying CY, Dominguez-Sola D, Fabi M et al (2013) MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nat Immunol 14:1084\u20131092","journal-title":"Nat Immunol"},{"key":"1_CR155","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","volume":"125","author":"M Yildiz","year":"2015","unstructured":"Yildiz M, Li H, Bernard D et al (2015) Activating STAT6 mutations in follicular lymphoma. Blood 125:668\u2013679","journal-title":"Blood"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","volume":"129","author":"K Krysiak","year":"2017","unstructured":"Krysiak K, Gomez F, White BS et al (2017) Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood 129:473\u2013483","journal-title":"Blood"},{"key":"1_CR157","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng.3473","volume":"48","author":"J Okosun","year":"2016","unstructured":"Okosun J, Wolfson RL, Wang J et al (2016) Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet 48:183\u2013188","journal-title":"Nat Genet"},{"key":"1_CR158","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","volume":"317","author":"LM Weiss","year":"1987","unstructured":"Weiss LM, Warnke RA, Sklar J et al (1987) Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185\u20131189","journal-title":"N Engl J Med"},{"key":"1_CR159","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1182\/blood.V77.5.1057.1057","volume":"77","author":"M Ladanyi","year":"1991","unstructured":"Ladanyi M, Offit K, Jhanwar SC et al (1991) MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 77:1057\u20131063","journal-title":"Blood"},{"key":"1_CR160","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","volume":"92","author":"K Gronbaek","year":"1998","unstructured":"Gronbaek K, Straten PT, Ralfkiaer E et al (1998) Somatic Fas mutations in non-Hodgkin\u2019s lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018\u20133024","journal-title":"Blood"},{"key":"1_CR161","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2002-02-0382","volume":"100","author":"K Gronbaek","year":"2002","unstructured":"Gronbaek K, Worm J, Ralfkiaer E et al (2002) ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood 100:1430\u20131437","journal-title":"Blood"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","volume":"90","author":"PR Koduru","year":"1997","unstructured":"Koduru PR, Raju K, Vadmal V et al (1997) Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin\u2019s lymphoma. Blood 90:4078\u20134091","journal-title":"Blood"},{"key":"1_CR163","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.leu.2401315","volume":"13","author":"MB Moller","year":"1999","unstructured":"Moller MB, Ino Y, Gerdes AM et al (1999) Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia 13:453\u2013459","journal-title":"Leukemia"},{"key":"1_CR164","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","volume":"114","author":"A Mottok","year":"2009","unstructured":"Mottok A, Renne C, Seifert M et al (2009) Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood 114:4503\u20134506","journal-title":"Blood"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1084\/jem.20052204","volume":"203","author":"L Pasqualucci","year":"2006","unstructured":"Pasqualucci L, Compagno M, Houldsworth J et al (2006) Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203:311\u2013317","journal-title":"J Exp Med"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2009-10-247122","volume":"116","author":"F Jardin","year":"2010","unstructured":"Jardin F, Jais JP, Molina TJ et al (2010) Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study. Blood 116:1092\u20131104","journal-title":"Blood"},{"key":"1_CR167","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","volume":"114","author":"K Honma","year":"2009","unstructured":"Honma K, Tsuzuki S, Nakagawa M et al (2009) TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 114:2467\u20132475","journal-title":"Blood"},{"key":"1_CR168","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW et al (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471:377\u2013381","journal-title":"Nature"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"I Melzner","year":"2005","unstructured":"Melzner I, Bucur AJ, Bruderlein S et al (2005) Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105:2535\u20132542","journal-title":"Blood"},{"key":"1_CR170","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","volume":"114","author":"O Ritz","year":"2009","unstructured":"Ritz O, Guiter C, Castellano F et al (2009) Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. Blood 114:1236\u20131242","journal-title":"Blood"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann ML, Bohle V et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981\u2013989","journal-title":"J Exp Med"},{"key":"1_CR172","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","volume":"128","author":"L Mansouri","year":"2016","unstructured":"Mansouri L, Noerenberg D, Young E et al (2016) Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood 128:2666\u20132670","journal-title":"Blood"},{"key":"1_CR173","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","volume":"13","author":"A Mottok","year":"2015","unstructured":"Mottok A, Woolcock B, Chan FC et al (2015) Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression. Cell Rep 13:1418\u20131431","journal-title":"Cell Rep"},{"key":"1_CR174","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ng.2900","volume":"46","author":"J Gunawardana","year":"2014","unstructured":"Gunawardana J, Chan FC, Telenius A et al (2014) Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat Genet 46:329\u2013335","journal-title":"Nat Genet"},{"key":"1_CR175","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/sj.leu.2403982","volume":"19","author":"D Rossi","year":"2005","unstructured":"Rossi D, Cerri M, Capello D et al (2005) Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19:2363\u20132366","journal-title":"Leukemia"},{"key":"1_CR176","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajh.24451","volume":"91","author":"F Jardin","year":"2016","unstructured":"Jardin F, Pujals A, Pelletier L et al (2016) Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Am J Hematol 91:923\u2013930","journal-title":"Am J Hematol"},{"key":"1_CR177","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","volume":"131","author":"E Vigano","year":"2018","unstructured":"Vigano E, Gunawardana J, Mottok A et al (2018) Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. Blood 131:2036\u20132046","journal-title":"Blood"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9440(10)64941-3","volume":"156","author":"C Cinti","year":"2000","unstructured":"Cinti C, Leoncini L, Nyongo A et al (2000) Genetic alterations of the retinoblastoma-related gene RB2\/p130 identify different pathogenetic mechanisms in and among Burkitt\u2019s lymphoma subtypes. Am J Pathol 156:751\u2013760","journal-title":"Am J Pathol"},{"key":"1_CR179","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter J, Schlesner M, Hoffmann S et al (2012) Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44:1316\u20131320","journal-title":"Nat Genet"},{"key":"1_CR180","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116\u2013120","journal-title":"Nature"},{"key":"1_CR181","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D et al (2012) The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321\u20131325","journal-title":"Nat Genet"},{"key":"1_CR182","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/bjh.14633","volume":"178","author":"T Menter","year":"2017","unstructured":"Menter T, Juskevicius D, Alikian M et al (2017) Mutational landscape of B-cell post-transplant lymphoproliferative disorders. Br J Haematol 178:48\u201356","journal-title":"Br J Haematol"},{"key":"1_CR183","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1038\/sj.onc.1202893","volume":"18","author":"E Cabannes","year":"1999","unstructured":"Cabannes E, Khan G, Aillet F et al (1999) Mutations in the IkBa gene in Hodgkin\u2019s disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18:3063\u20133070","journal-title":"Oncogene"},{"key":"1_CR184","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.onc.1202351","volume":"18","author":"D Krappmann","year":"1999","unstructured":"Krappmann D, Emmerich F, Kordes U et al (1999) Molecular mechanisms of constitutive NF-kappaB\/Rel activation in Hodgkin\/Reed-Sternberg cells. Oncogene 18:943\u2013953","journal-title":"Oncogene"},{"key":"1_CR185","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1084\/jem.191.2.395","volume":"191","author":"B Jungnickel","year":"2000","unstructured":"Jungnickel B, Staratschek-Jox A, Br\u00e4uninger A et al (2000) Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin\u2019s lymphoma. J Exp Med 191:395\u2013402","journal-title":"J Exp Med"},{"key":"1_CR186","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/path.1454","volume":"201","author":"F Emmerich","year":"2003","unstructured":"Emmerich F, Theurich S, Hummel M et al (2003) Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells. J Pathol 201:413\u2013420","journal-title":"J Pathol"},{"key":"1_CR187","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","volume":"25","author":"MA Weniger","year":"2006","unstructured":"Weniger MA, Melzner I, Menz CK et al (2006) Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25:2679\u20132684","journal-title":"Oncogene"},{"key":"1_CR188","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel J, Chadburn A, Rubinstein PG et al (2015) Flow-sorting and exome sequencing reveals the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 125:1061\u20131072","journal-title":"Blood"},{"key":"1_CR189","doi-asserted-by":"crossref","unstructured":"Tiacci E, Ladewig E, Schiavoni G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood","DOI":"10.1182\/blood-2017-11-814913"},{"key":"1_CR190","doi-asserted-by":"publisher","first-page":"111386","DOI":"10.18632\/oncotarget.22799","volume":"8","author":"E Mata","year":"2017","unstructured":"Mata E, Diaz-Lopez A, Martin-Moreno AM et al (2017) Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. Oncotarget 8:111386\u2013111395","journal-title":"Oncotarget"},{"key":"1_CR191","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","volume":"99","author":"JI Martin-Subero","year":"2002","unstructured":"Martin-Subero JI, Gesk S, Harder L et al (2002) Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99:1474\u20131477","journal-title":"Blood"},{"key":"1_CR192","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","volume":"4","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Stanelle J, Hansmann ML et al (2009) Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol 4:151\u2013174","journal-title":"Annu Rev Pathol"},{"key":"1_CR193","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2141.2012.09113.x","volume":"157","author":"C Otto","year":"2012","unstructured":"Otto C, Giefing M, Massow A et al (2012) Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma. Br J Haematol 157:702\u2013708","journal-title":"Br J Haematol"},{"key":"1_CR194","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","volume":"116","author":"C Steidl","year":"2010","unstructured":"Steidl C, Telenius A, Shah SP et al (2010) Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 116:418\u2013427","journal-title":"Blood"},{"key":"1_CR195","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"A Mottok","year":"2007","unstructured":"Mottok A, Renn\u00e9 C, Willenbrock K et al (2007) Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110:3387\u20133390","journal-title":"Blood"},{"key":"1_CR196","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Schuhmacher B, Rausch T et al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30:844\u2013853","journal-title":"Leukemia"},{"key":"1_CR197","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi D, Trifonov V, Fangazio M et al (2012) The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 209:1537\u20131551","journal-title":"J Exp Med"},{"key":"1_CR198","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2014.330","volume":"29","author":"A Clipson","year":"2015","unstructured":"Clipson A, Wang M, de Leval L et al (2015) KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia 29:1177\u20131185","journal-title":"Leukemia"},{"key":"1_CR199","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","volume":"154","author":"M Mateo","year":"1999","unstructured":"Mateo M, Mollejo M, Villuendas R et al (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 154:1583\u20131589","journal-title":"Am J Pathol"},{"key":"1_CR200","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","volume":"39","author":"A Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez A, Curiel-Olmo S, Mollejo M et al (2015) MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol 39:644\u2013651","journal-title":"Am J Surg Pathol"},{"key":"1_CR201","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","volume":"130","author":"BH Durham","year":"2017","unstructured":"Durham BH, Getta B, Dietrich S et al (2017) Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood 130:1644\u20131648","journal-title":"Blood"},{"key":"1_CR202","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood-2015-04-643361","volume":"126","author":"S Dietrich","year":"2015","unstructured":"Dietrich S, H\u00fcllein J, Lee SC et al (2015) Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood 126:1005\u20131008","journal-title":"Blood"},{"key":"1_CR203","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G et al (2011) BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305\u20132315","journal-title":"N Engl J Med"},{"key":"1_CR204","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","volume":"96","author":"TG Willis","year":"1999","unstructured":"Willis TG, Jadayel DM, Du MQ et al (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35\u201345","journal-title":"Cell"},{"key":"1_CR205","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/8767","volume":"22","author":"Q Zhang","year":"1999","unstructured":"Zhang Q, Siebert R, Yan M et al (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22:63\u201368","journal-title":"Nat Genet"},{"key":"1_CR206","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","volume":"101","author":"B Streubel","year":"2003","unstructured":"Streubel B, Lamprecht A, Dierlamm J et al (2003) T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101:2335\u20132339","journal-title":"Blood"},{"key":"1_CR207","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/sj.leu.2403644","volume":"19","author":"B Streubel","year":"2005","unstructured":"Streubel B, Vinatzer U, Lamprecht A et al (2005) T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19:652\u2013658","journal-title":"Leukemia"},{"key":"1_CR208","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/modpathol.3800400","volume":"18","author":"H Takino","year":"2005","unstructured":"Takino H, Okabe M, Li C et al (2005) p16\/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis. Mod Pathol 18:1187\u20131192","journal-title":"Mod Pathol"},{"key":"1_CR209","doi-asserted-by":"publisher","first-page":"62627","DOI":"10.18632\/oncotarget.11548","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson P, Klein-Hitpass L, Grabellus F et al (2016) Recurrent mutations in NF-kappaB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas. Oncotarget 7:62627\u201362639","journal-title":"Oncotarget"},{"key":"1_CR210","doi-asserted-by":"crossref","unstructured":"Moody S, Thompson JS, Chuang SS et al (2018) Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica","DOI":"10.3324\/haematol.2018.191601"},{"key":"1_CR211","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1182\/blood.V88.11.4110.4110","volume":"88","author":"S Iida","year":"1996","unstructured":"Iida S, Rao PH, Nallasivam P et al (1996) The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110\u20134117","journal-title":"Blood"},{"key":"1_CR212","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G et al (2012) MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med 367:826\u2013833","journal-title":"N Engl J Med"},{"key":"1_CR213","first-page":"5640","volume":"58","author":"H Avet-Loiseau","year":"1998","unstructured":"Avet-Loiseau H, Li JY, Facon T et al (1998) High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res 58:5640\u20135645","journal-title":"Cancer Res"},{"key":"1_CR214","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","volume":"16","author":"M Chesi","year":"1997","unstructured":"Chesi M, Nardini E, Brents LA et al (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260\u2013264","journal-title":"Nat Genet"},{"key":"1_CR215","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457.412k48_4457_4463","volume":"91","author":"M Chesi","year":"1998","unstructured":"Chesi M, Bergsagel PL, Shonukan OO et al (1998) Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457\u20134463","journal-title":"Blood"},{"key":"1_CR216","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","volume":"90","author":"TH Landowski","year":"1997","unstructured":"Landowski TH, Qu N, Buyuksal I et al (1997) Mutations in the Fas antigen in patients with multiple myeloma. Blood 90:4266\u20134270","journal-title":"Blood"},{"key":"1_CR217","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.97.1.228","volume":"97","author":"Y Shou","year":"2000","unstructured":"Shou Y, Martelli ML, Gabrea A et al (2000) Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci USA 97:228\u2013233","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR218","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","volume":"88","author":"P Liu","year":"1996","unstructured":"Liu P, Leong T, Quam L et al (1996) Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood 88:2699\u20132706","journal-title":"Blood"},{"key":"1_CR219","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-10-1843","volume":"17","author":"NC Munshi","year":"2011","unstructured":"Munshi NC, Avet-Loiseau H (2011) Genomics in multiple myeloma. Clin Cancer Res 17:1234\u20131242","journal-title":"Clin Cancer Res"},{"key":"1_CR220","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1084\/jem.182.2.559","volume":"182","author":"DK Dunn-Walters","year":"1995","unstructured":"Dunn-Walters DK, Isaacson PG, Spencer J (1995) Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 182:559\u2013566","journal-title":"J Exp Med"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4188-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:02:14Z","timestamp":1729278134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4188-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"ISBN":["9781071641873","9781071641880"],"references-count":220,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4188-0_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"19 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}